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ABSTRACT 
 
Ageing in humans refers to a biological process of life 
engaged with physical, psychological, and social changes. 
Different species of animals age at radically different paces 
and occurrences of diseases. Drug designing approaches 
related to an aging factor, Type 2 Diabetes mellitus has 
been reported in the present study. Resveratrol and human 
Sirtuins (1 to 6) are docked against Type 2 Diabetes 
mellitus HNF-1a motif with PDB ID:  2GYP using Hex 
5.1.  Resveratrol and Sirtuin 6 shown good results and can 
use as anti-aging drugs against Type 2 Diabetes mellitus. 
 
Key words: Drug designing, ageing, Type 2 Diabetes 
mellitus, Docking. 
 
 
 
INTRODUCTION 
 
Ageing (British English) or aging (American English) is the 
accumulation of changes in an organism or object over 
time1. Ageing in humans refers to a biological and 
systematic process of life engaged with physical, 
psychological, and social changes. Various research 
activities presented that even late in life potential exists for 
physical, mental, and social growth and development2. 
Ageing is an important part of all human beings reflecting 
the biological changes that occur, and is also reflecting 
cultural and societal conventions. Indeed, aging is not an 
unavoidable property of life process but it is indeed the 
result of a genetic program3. 
 
In the early twentieth century, the study of aging focused 
primarily on biomedical models of pathology, that is, how 
to diagnose the diseases and chronic disabilities afflicting 
the elderly, and how best to treat them. It is safe to say that 
most of scientists studying aging prior to  l980s proposed 
that “aging as a rising wall of mortality”4.  
 
Aging research crosses all areas of physiology and also 
relies upon biological, mathematical, and chemical tools for 
its study. The rapid rise of biological, biomedical and 
behavioral research on aging beginning in the 1970s was a 
response to the growing realization of both the scientific 
and political establishments that the American population 
was aging and that the Baby Boomers would reach 
retirement in less than 50 years, an eternity for politicians 
and a moment for scientists5.  
 
The sirtuin family of genes has been shown to have a 
significant effect on the lifespan of yeast and nematodes6. 
Most of the drug companies are currently searching for 
ways to synthesize and mimic the lifespan-extending 
effects of caloric restriction without having to severely 
reduce food consumption. 
 
Silent information regulator (Sir) proteins, or sirtuins, are a 
class of proteins which possess either histone deacetylase 
or mono-ribosyltransferase activity and are found in 
organisms ranging from bacteria to humans7,8. Sirtuins have 
been concerned in the process of regulation of aging, 
transcription, apoptosis and stress resistance. Regulation of 
metabolic processes as well as cellular defense mechanisms 
might ultimately be the key to a possible lifespan-extending 
role for sirtuins in mammals. Based on previous research, 
mammals possess seven types of  sirtuins (SIRT 1 to 7) that 
occupy different subcellular compartments such as the 
nucleus (SIRT1, -2, -6, -7), cytoplasm (SIRT1 and SIRT2) 
and the mitochondria (SIRT3, -4 and -5)9. Sirtuins may be 
of therapeutic utility for type II diabetes mellitus10. The 
polyphenolic compound called Resveratrol is a naturally 
occurring phytochemical and can be found in most of the 
plant species, including grapes, peanuts and various herbs 
and shrubs 11. Several studies show that Resveratrol, found 
in red wine, can inhibit this interaction and is a putative 
agent for slowing down the aging process12.  
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MATERIALS AND METHODS 
 
In this work, we attempted to carry out the drug designing 
with the following infrastructure.  
 
SYSTEM USED –Intel Pentium 4 GHz, 2GB RAM 
 
OPERATING PLATFORM- Microsoft Windows XP pro 
2002 service pack 
 
SOFTWARE PACKAGES - ISIS /Draw 2.5SP4, 
ARGUSLAB 4.0.1, HEX 5.1 
 
PROTEIN- 2GYP.pdb 
 
  
One of the PDB Structure related to Diabetes mellitus 
caused due to a frustrated Schellman motif in HNF-1a with 
PDB id 2GYP was selected as receptor  
 
Protein sequences related to sertuin is randomly selected 
from NCBI database with Accession numbers 
1NP_036370(Sir1), AAD40850(Sir2), AAD40851(Sir3), 
NP_036372(Sir4), AAD40853 (Sir5), NP_057623 (Sir6) 
and NP_057622(Sir7). These sequences are submitted to 
Swissmodel for identification of template molecules for 
docking. The ligand designed on ISIS/Draw is Resveratrol, 
optimized by Argus and is also used for docking process.  
 
Docking studies are done using Hex 5.1 software. 
 
RESULTS AND DISCUSSION 
 
Diabetes Mellitus is the most prevalent chronic disease in 
the world affecting nearly 25% of the population. 
Bioinformatics and cheminformatics are emerging fields 
with the potential to significantly improve the activity of 
drugs against diseased molecules commercially supplied to 
the marketplace13.  
 
Templates from Sir1 to Sir6 are shown in FIGURE 1. 
 
Various sirtuins and Resveratrol are selected as ligands for 
the present study. FIGURE 2 provides the process of 
designing and optimization of Resveratrol. The designed 
and optimized structure of Resveratrol is shown in 
FIGURE 3. 
 
The selected receptor is displayed in FIGURE 4. 
 
The distances of Ligand and Receptor have been provided 
in Table 1.  
Resveratrol and Sirtuin 6 shown good result and can use as 
anti-aging drugs against Type 2 Diabetes mellitus. 
 
 
FIGURE 1: SWISSMODELED STRUCTURES OF SIRTUINS 1 TO 6  
(DISPLAYED IN ARGUS) 
 
Sir1                                                           Sir 2 
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Sir 3      Sir4 
 
 
Sir 5                                                                Sir 6 
 
 
 
 
 
FIGURE 2: DESIGNING AND OPTIMISATION OF RESVERATROL 
 
A: Resveratrol Designed in ISIS /Draw                                                  B:Designed molecule from Argus 
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C:Parameters selected with UFF in Argus                                       D:After running the designed molecule, 
                                                                                                          the optimized structure displayed in Argus 
                                     
FIGURE 3: DESIGNED AND OPTIMISED DRUG 
 
Resveratrol 
 
FIGURE 4: 2GYP.PDB MODEL FROM PROTEIN DATABANK (PDB)  
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TABLE 1: DISTANCE FROM LIGAND AND 
RECEPTOR IN ANGSTROMS 
 
Drug/Fatty acid 2GYP(Diabetes 
causing molecule) 
Resveratrol 3.8 
Sirtuin 1 43.5 
Sirtuin 2 43.9 
Sirtuin 3 28.9 
Sirtuin 4 43.5 
Sirtuin 5 43.9                                     
Sirtuin 6 17.6 
 
 
 
CONCLUSION 
Studies based on computational approaches can provide 
better results based on docking. Further studies using 
phytocompounds can provide cure against aging diseases 
such as Diabetes, Alzheimer, Parkinson, Rheumatoid 
Arthritis etc. 
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